The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Dec. 08, 2015
Applicants:

Human Matrix Sciences, Llc, Visalia, CA (US);

The Hospital for Sick Children, Toronto, CA;

Inventors:

Thomas Mitts, Visalia, CA (US);

Felipe Jimenez, Seal Beach, CA (US);

Aleksander Hinek, Toronto, CA;

Assignees:

Human Matrix Services, LLC, Visalia, CA (US);

The Hospital for Sick Children, Toronto, Ontario, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2006.01); A61K 8/02 (2006.01); A61K 8/60 (2006.01); A61K 31/05 (2006.01); A61Q 19/08 (2006.01); A61K 31/352 (2006.01); A61K 31/7028 (2006.01); A61K 8/49 (2006.01); A61K 8/64 (2006.01); A61K 31/366 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 8/02 (2013.01); A61K 8/498 (2013.01); A61K 8/60 (2013.01); A61K 8/602 (2013.01); A61K 8/64 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 31/366 (2013.01); A61K 31/7028 (2013.01); A61K 45/06 (2013.01); A61Q 19/08 (2013.01); A61K 2800/91 (2013.01);
Abstract

Dermal fibroblasts permanently loose their ability to synthesize elastin, the major component of elastic fibers, shortly after puberty. This progressive loss of elastic fibers cannot be replaced, resulting in the physical signs of aging. The present invention provides methods and compositions containing the polyphenols ellagic acid and/or tannic acid for protection against degradation of cutaneous elastic fibers by the elastolytic enzymes. The use of ellagic acid and/or tannic acid increased the overall deposition of elastic fibers in healthy and damaged skin cells. The protection of both intra-tropoelastin and extra-cellular mature elastic fibers from proteolytic enzymes by ellagic acid and tannic acid caused an increase in the net deposition of elastic fibers. Therefore, embodiments of the present invention provide methods and composition for the treatment of skin and prevention and treatment of degradation of dermal elastic fibers.


Find Patent Forward Citations

Loading…